U.S. market Closed. Opens in 20 minutes

KZR | Kezar Life Sciences, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue7.00MN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue1.07M1.02M1.51M1.54M1.30MN/AN/AN/A
Gross Profit5.93M-1.02M-1.51M-1.54M-1.30MN/AN/AN/A
Operating Expenses111.17M71.16M54.66M42.95M37.34M24.73M8.75MN/A
Selling, General & Admin25.47M20.15M15.72M11.97M9.98M6.59M2.28M1.62M
Research & Development85.70M51.01M38.94M30.98M27.36M18.14M6.47M7.37M
Other Operating Expenses6.19MN/AN/AN/AN/AN/AN/AN/A
Operating Income-105.24M-71.16M-54.66M-42.95M-37.34M-24.73M-8.75M-8.99M
Other Expenses / Income3.37M2.92M29.00K1.21M2.25M1.56M232.00KN/A
Before Tax Income-101.87M-68.24M-54.63M-41.74M-35.09M-23.17M-8.52M-8.99M
Income Tax Expenses898.11K-2.92M-1.35M-2.75M-3.56M1.56MN/AN/A
Net Income-101.87M-65.32M-53.28M-38.99M-31.53M-23.17M-8.52M-8.99M
Interest Expenses1.55M1.19M159.00KN/AN/AN/AN/AN/A
Basic Shares Outstanding72.55M67.37M52.76M44.00M19.08M10.26M9.76M13.02M
Diluted Shares Outstanding72.55M67.37M52.76M44.00M19.08M10.26M9.76M13.02M
EBITDA-104.17M-71.16M-54.47M-42.95M-37.34M-24.73M-8.34M-8.84M
EBITDA Margin-1,488.16%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-99.42M-67.05M-54.47M-41.74M-35.09M-21.61M-8.52M-8.99M
EBIT Margin-1,420.31%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙